Core Viewpoint - The article emphasizes the rising importance of brain-computer interfaces (BCI) in the investment landscape, driven by policy support and technological advancements, marking it as a key area for investors in the upcoming years [3][4]. Policy and Market Dynamics - The Chinese government has included BCI in its "14th Five-Year Plan" as one of the six key future industries, indicating strong policy backing [3]. - The National Healthcare Security Administration has integrated BCI into the medical insurance system, establishing a preliminary commercial closed loop [5]. Technological Advancements - Significant breakthroughs in invasive and semi-invasive BCI technologies have been achieved, with domestic teams making progress that rivals international leaders [6][7]. - A notable development includes the creation of high-throughput, stretchable flexible electrodes, which address issues faced by traditional electrodes during dynamic brain movements [8]. Clinical Applications and Trials - Clinical trials have shown promising results, with a semi-invasive BCI system improving hand function in patients with spinal cord injuries [9]. - Neuralink has made strides in its invasive BCI technology, achieving FDA breakthrough device designation for its brain chip implants [10]. Non-Invasive Applications - Non-invasive BCIs are gaining traction in rehabilitation and consumer electronics, with a focus on their ease of use and portability [11]. - Domestic research teams have developed non-invasive solutions that are cost-effective and show high product viability [11]. Capital Market Trends - The investment landscape for BCI is heating up, with nearly 30 financing rounds completed in the sector this year, totaling over 5 billion yuan [16]. - Companies like BrainCo have raised significant funds and are preparing for IPOs, indicating strong market interest [16][17].